Clinical Trial Update: Delayed Pelvic Imaging With [68]Ga-PSMA PET/CT in a Patient With High-risk Prostate Cancer. [NA]

View source ↗

Summary

This clinical trial update notes recruitment for a study evaluating delayed pelvic imaging with [68]Ga-PSMA PET/CT in high-risk prostate cancer. The status is R…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• [68]Ga-PSMA PET/CT (Gallium-68 labeled PSMA radiopharmaceutical for PET imaging)

Snippet

Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna | Conditions: High-risk Prostate Cancer | NA | Status: RECRUITING